Article info
Cancer genetics
Short report
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
- Correspondence to Dr Q Waisfisz, VU University Medical Centre, Amsterdam, Department of Clinical Genetics, section Oncogenetics, Van der Boechorststraat 7, 1081 BT Amsterdam, The Netherlands; q.waisfisz{at}vumc.nl
Citation
CHEK2*1100delC homozygosity is associated with a high breast cancer risk in women
Publication history
- Received July 27, 2011
- Accepted October 13, 2011
- First published November 5, 2011.
Online issue publication
April 27, 2016
Article Versions
- Previous version (27 April 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.